miR-17-5p is an oncogenic miRNA that regulates cancer development and progression by targeting P130 (RB transcriptional co-repressor like 2, RBL2) and subsequently activating the Wnt/β-catenin pathway [177]. The gene discussed is RBL2; the disease is cancer.